A FRET-based high-throughput screening platform for the discovery of chemical probes targeting the scaffolding functions of human tankyrases.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 07 2020
Historique:
received: 01 04 2020
accepted: 02 07 2020
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 15 12 2020
Statut: epublish

Résumé

Tankyrases catalyse poly-ADP-ribosylation of their binding partners and the modification serves as a signal for the subsequent proteasomal degradation of these proteins. Tankyrases thereby regulate the turnover of many proteins involved in multiple and diverse cellular processes, such as mitotic spindle formation, telomere homeostasis and Wnt/β-catenin signalling. In recent years, tankyrases have become attractive targets for the development of inhibitors as potential therapeutics against cancer and fibrosis. Further, it has become clear that tankyrases are not only enzymes, but also act as scaffolding proteins forming large cellular signalling complexes. While many potent and selective tankyrase inhibitors of the poly-ADP-ribosylation function exist, the inhibition of tankyrase scaffolding functions remains scarcely explored. In this work we present a robust, simple and cost-effective high-throughput screening platform based on FRET for the discovery of small molecule probes targeting the protein-protein interactions of tankyrases. Validatory screening with the platform led to the identification of two compounds with modest binding affinity to the tankyrase 2 ARC4 domain, demonstrating the applicability of this approach. The platform will facilitate identification of small molecules binding to tankyrase ARC or SAM domains and help to advance a structure-guided development of improved chemical probes targeting tankyrase oligomerization and substrate protein interactions.

Identifiants

pubmed: 32704068
doi: 10.1038/s41598-020-69229-y
pii: 10.1038/s41598-020-69229-y
pmc: PMC7378079
doi:

Substances chimiques

Fluorescent Dyes 0
TNKS2 protein, human EC 2.4.2.30
Tankyrases EC 2.4.2.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12357

Références

Hsiao, S. J. & Smith, S. Tankyrase function at telomeres, spindle poles, and beyond. Biochimie 90, 83–92 (2008).
pubmed: 17825467
Haikarainen, T., Krauss, S. & Lehtiö, L. Tankyrases: Structure, function and therapeutic implications in cancer. Curr. Pharm. Des. 20, 6472–6488 (2014).
pubmed: 24975604 pmcid: 4262938
Mariotti, L., Pollock, K. & Guettler, S. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. Br. J. Pharmacol. 174, 4611–4636 (2017).
pubmed: 28910490 pmcid: 5727255
Kim, M. K. Novel insight into the function of tankyrase. Oncol. Lett. 16, 6895–6902 (2018).
pubmed: 30546421 pmcid: 6256358
Palazzo, L. & Ahel, I. PARPs in genome stability and signal transduction: Implications for cancer therapy. Biochem. Soc. Trans. 46, 1681–1695 (2018).
pubmed: 30420415 pmcid: 6299239
Chiang, Y. J. et al. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS ONE 3, e2639 (2008).
pubmed: 18612384 pmcid: 2441437
Kaminker, P. G. et al. TANK2, a New TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J. Biol. Chem. 276, 35891–35899 (2001).
pubmed: 11454873
Rippmann, J. F., Damm, K. & Schnapp, A. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. J. Mol. Biol. 323, 217–224 (2002).
pubmed: 12381316
Smith, S., Giriat, I., Schmitt, A. & de Lange, T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484–1487 (1998).
pubmed: 9822378
Hottiger, M. O., Hassa, P. O., Lüscher, B., Schüler, H. & Koch-Nolte, F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 35, 208–219 (2010).
pubmed: 20106667
Callow, M. G. et al. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. PLoS ONE 6, e22595 (2011).
pubmed: 21799911 pmcid: 3143158
Chang, W., Dynek, J. N. & Smith, S. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 17, 1328–1333 (2003).
pubmed: 12782650 pmcid: 196064
Morrone, S., Cheng, Z., Moon, R. T., Cong, F. & Xu, W. Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment. PNAS 109, 1500–1505 (2012).
pubmed: 22307604
Huang, S.-M.A. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614–620 (2009).
pubmed: 19759537
Smith, S. & de Lange, T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10, 1299–1302 (2000).
pubmed: 11069113
Seimiya, H., Muramatsu, Y., Smith, S. & Tsuruo, T. Functional subdomain in the ankyrin domain of tankyrase 1 required for poly(ADP-Ribosyl)ation of TRF1 and telomere elongation. Mol. Cell. Biol. 24, 1944–1955 (2004).
pubmed: 14966275 pmcid: 350561
Chang, W., Dynek, J. N. & Smith, S. NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem. J. 391, 177–184 (2005).
pubmed: 16076287 pmcid: 1276914
Chang, P., Coughlin, M. & Mitchison, T. J. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat. Cell Biol. 7, 1133–1139 (2005).
pubmed: 16244666
Chang, P., Coughlin, M. & Mitchison, T. J. Interaction between poly(ADP-ribose) and NuMA contributes to mitotic spindle pole assembly. MBoC 20, 4575–4585 (2009).
pubmed: 19759176
Lehtiö, L., Chi, N.-W. & Krauss, S. Tankyrases as drug targets. FEBS J. 280, 3576–3593 (2013).
pubmed: 23648170
Thorvaldsen, T. E. Targeting tankyrase to fight WNT-dependent tumours. Basic Clin. Pharmacol. Toxicol. 121, 81–88 (2017).
pubmed: 28371398
Riffell, J. L., Lord, C. J. & Ashworth, A. Tankyrase-targeted therapeutics: Expanding opportunities in the PARP family. Nat. Rev. Drug Discov. 11, 923–936 (2012).
pubmed: 23197039
Mariotti, L. et al. Tankyrase requires SAM domain-dependent polymerization to support Wnt-β-catenin signaling. Mol. Cell 63, 498–513 (2016).
pubmed: 27494558 pmcid: 4980433
DaRosa, P. A., Ovchinnikov, S., Xu, W. & Klevit, R. E. Structural insights into SAM domain-mediated tankyrase oligomerization. Protein Sci. 25, 1744–1752 (2016).
pubmed: 27328430 pmcid: 5338228
Riccio, A. A., McCauley, M., Langelier, M.-F. & Pascal, J. M. Tankyrase sterile α motif domain polymerization is required for its role in Wnt signaling. Structure 24, 1573–1581 (2016).
pubmed: 27499439 pmcid: 5109827
Kim, C. A. & Bowie, J. U. SAM domains: Uniform structure, diversity of function. Trends Biochem. Sci. 28, 625–628 (2003).
pubmed: 14659692
Qiao, F. & Bowie, J. U. The many faces of SAM. Science STKE 2005, re7 (2005).
Schultz, J., Ponting, C. P., Hofmann, K. & Bork, P. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 6, 249–253 (1997).
pubmed: 9007998 pmcid: 2143507
Fan, C. et al. Regulation of tankyrase activity by a catalytic domain dimer interface. Biochem. Biophys. Res. Commun. 503, 1780–1785 (2018).
pubmed: 30055800 pmcid: 6132069
DaRosa, P. A., Klevit, R. E. & Xu, W. Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs. Protein Sci. 27, 1057–1067 (2018).
pubmed: 29604130 pmcid: 5980575
Guettler, S. et al. Structural basis and sequence rules for substrate recognition by tankyrase explain the basis for cherubism disease. Cell 147, 1340–1354 (2011).
pubmed: 22153077
Pollock, K., Ranes, M., Collins, I. & Guettler, S. Identifying and validating tankyrase binders and substrates: A candidate approach. Methods Mol. Biol. 1608, 445–473 (2017).
pubmed: 28695526 pmcid: 6082341
Eisemann, T. et al. Tankyrase-1 Ankyrin repeats form an adaptable binding platform for targets of ADP-ribose modification. Structure 24, 1679–1692 (2016).
pubmed: 27594684
Xu, W. et al. Macrocyclized extended peptides: Inhibiting the substrate-recognition domain of tankyrase. J. Am. Chem. Soc. 139, 2245–2256 (2017).
pubmed: 28084734 pmcid: 5358875
Cheng, H. et al. Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation. Cancer Lett. 443, 80–90 (2019).
pubmed: 30472184
Pollock, K. et al. Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase. Sci. Rep. 9, 1–20 (2019).
Song, Y., Rodgers, V. G. J., Schultz, J. S. & Liao, J. Protein interaction affinity determination by quantitative FRET technology. Biotechnol. Bioeng. 109, 2875–2883 (2012).
pubmed: 22711490
Song, Y. & Liao, J. An In vitro Förster resonance energy transfer-based high-throughput screening assay for inhibitors of protein–protein interactions in SUMOylation pathway. Assay Drug. Dev. Technol 10, 336–343 (2012).
pubmed: 22192309 pmcid: 3419857
Zhang, J.-H., Chung, T. D. Y. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67–73 (1999).
pubmed: 10838414
Makley, L. N. & Gestwicki, J. E. Expanding the number of ‘druggable’ targets: Non-enzymes and protein-protein interactions. Chem. Biol. Drug Des. 81, 22–32 (2013).
pubmed: 23253128 pmcid: 3531880
Baron, B. M. et al. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol. Pharmacol. 38, 554–561 (1990).
pubmed: 2172769
Turski, L. et al. ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. PNAS 95, 10960–10965 (1998).
pubmed: 9724812
Langelier, M.-F., Eisemann, T., Riccio, A. A. & Pascal, J. M. PARP family enzymes: Regulation and catalysis of the poly(ADP-ribose) posttranslational modification. Curr. Opin. Struct. Biol. 53, 187–198 (2018).
pubmed: 30481609 pmcid: 6687463
Jeong, J.-Y. et al. One-step sequence- and ligation-independent cloning as a rapid and versatile cloning method for functional genomics studies. Appl. Environ. Microbiol. 78, 5440–5443 (2012).
pubmed: 22610439 pmcid: 3416421
Hynes, M. F., Quandt, J., O’Connell, M. P. & Pühler, A. Direct selection for curing and deletion of rhizobium plasmids using transposons carrying the Bacillus subtilis sacB gene. Gene 78, 111–120 (1989).
pubmed: 2548927
Reyrat, J.-M., Pelicic, V., Gicquel, B. & Rappuoli, R. Counterselectable markers: Untapped tools for bacterial genetics and pathogenesis. Infect. Immun. 66, 4011–4017 (1998).
pubmed: 9712740 pmcid: 108478
Nathubhai, A. et al. Highly potent and isoform selective dual site binding tankyrase/wnt signaling inhibitors that increase cellular glucose uptake and have antiproliferative activity. J. Med. Chem. 60, 814–820 (2017).
pubmed: 27983846

Auteurs

Sven T Sowa (ST)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Carlos Vela-Rodríguez (C)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Albert Galera-Prat (A)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Mariana Cázares-Olivera (M)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Renata Prunskaite-Hyyryläinen (R)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Alexander Ignatev (A)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

Lari Lehtiö (L)

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland. lari.lehtio@oulu.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH